Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

SPECIALLÆGESELSKABET BØRNEKLINIKKEN RANDERS ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.7%   Bankruptcy risk   3.3% 2.8% 3.1% 3.4% 4.0% 3.9% 27.3% 24.2%   Credit score (0-100)   57 60 56 53 49 49 2 3   Credit rating   BBB BBB BBB BBB BBB BBB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   4,805 4,387 4,450 4,536 4,340 4,773 4,773 4,773   Gross profit   4,074 3,539 3,550 3,770 3,571 3,972 0.0 0.0   EBITDA   1,411 864 936 1,099 769 1,192 0.0 0.0   EBIT   1,317 741 810 975 666 1,148 0.0 0.0   Pre-tax profit (PTP)   1,316.4 737.8 793.8 956.6 650.3 1,146.6 0.0 0.0   Net earnings   1,031.0 575.5 619.1 746.1 506.8 894.1 0.0 0.0   Pre-tax profit without non-rec. items   1,316 738 794 957 650 1,147 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   470 348 284 160 62.9 18.4 0.0 0.0   Shareholders equity total   1,177 723 767 894 655 1,043 24.0 24.0   Interest-bearing liabilities   1,932 1,982 1,947 2,140 1,456 1,587 0.0 0.0   Balance sheet total (assets)   3,748 3,268 3,440 3,470 2,550 3,000 24.0 24.0   Net Debt   -892 -532 -883 -810 -647 -1,031 -24.0 -24.0     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   4,805 4,387 4,450 4,536 4,340 4,773 4,773 4,773   Net sales growth   3.8% -8.7% 1.4% 1.9% -4.3% 10.0% 0.0% 0.0%   Gross profit   4,074 3,539 3,550 3,770 3,571 3,972 0.0 0.0   Gross profit growth   4.4% -13.1% 0.3% 6.2% -5.3% 11.2% -100.0% 0.0%   Employees   0 0 0 0 0 5 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,748 3,268 3,440 3,470 2,550 3,000 24 24   Balance sheet change%   8.6% -12.8% 5.2% 0.9% -26.5% 17.6% -99.2% 0.0%   Added value   1,410.7 864.3 935.7 1,099.4 790.5 1,192.1 0.0 0.0   Added value %   29.4% 19.7% 21.0% 24.2% 18.2% 25.0% 0.0% 0.0%   Investments   149 -245 -113 -248 -198 -81 -105 0   Net sales trend   1.0 -1.0 1.0 2.0 -1.0 1.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   29.4% 19.7% 21.0% 24.2% 17.7% 25.0% 0.0% 0.0%   EBIT %   27.4% 16.9% 18.2% 21.5% 15.4% 24.0% 0.0% 0.0%   EBIT to gross profit (%)   32.3% 20.9% 22.8% 25.9% 18.7% 28.9% 0.0% 0.0%   Net Earnings %   21.5% 13.1% 13.9% 16.5% 11.7% 18.7% 0.0% 0.0%   Profit before depreciation and extraordinary items %   23.4% 15.9% 16.8% 19.2% 14.0% 19.7% 0.0% 0.0%   Pre tax profit less extraordinaries %   27.4% 16.8% 17.8% 21.1% 15.0% 24.0% 0.0% 0.0%   ROA %   36.6% 21.1% 24.1% 28.2% 22.1% 41.4% 0.0% 0.0%   ROI %   43.3% 25.4% 29.8% 33.9% 25.9% 48.4% 0.0% 0.0%   ROE %   90.7% 60.6% 83.1% 89.8% 65.4% 105.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   31.4% 22.1% 22.3% 25.8% 25.7% 34.8% 100.0% 100.0%   Relative indebtedness %   53.3% 57.8% 60.0% 56.8% 43.7% 41.0% 0.0% 0.0%   Relative net indebtedness %   -5.5% 0.5% -3.6% -8.3% -4.8% -13.8% -0.5% -0.5%   Net int. bear. debt to EBITDA, %   -63.2% -61.6% -94.4% -73.7% -84.1% -86.5% 0.0% 0.0%   Gearing %   164.1% 274.2% 253.8% 239.4% 222.3% 152.1% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.2% 0.8% 0.9% 0.9% 0.1% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.2 1.1 1.2 1.3 1.3 1.5 0.0 0.0   Current Ratio   1.2 1.1 1.2 1.3 1.3 1.5 0.0 0.0   Cash and cash equivalent   2,824.1 2,514.4 2,829.6 2,950.5 2,102.3 2,617.4 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   14.8 17.6 20.3 21.5 23.1 14.4 0.0 0.0   Trade creditors turnover (days)   1.5 0.8 0.3 0.6 2.0 1.5 0.0 0.0   Current assets / Net sales %   65.5% 63.7% 69.2% 71.3% 55.5% 60.7% 0.5% 0.5%   Net working capital   588.5 255.8 407.3 657.2 513.4 937.9 0.0 0.0   Net working capital %   12.2% 5.8% 9.2% 14.5% 11.8% 19.7% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 955 0 0   Added value / employee   0 0 0 0 0 238 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 238 0 0   EBIT / employee   0 0 0 0 0 230 0 0   Net earnings / employee   0 0 0 0 0 179 0 0